Developing a Test to Detect Aggressive Prostate Cancer

Dr. Fred Saad

Prostate cancer tends to be a slow growing disease and some men can safely take advantage of active surveillance instead of going under the knife or having radiation. However, some cases are aggressive and should be treated with surgery or radiation right away.

Dr. Saad’s research is aimed at identifying these cases. He has found significant links between a group of proteins, called nuclear factor-kappa B (NFKB), and prostate cancer. In surgically removed prostates, he found that NFKB’s presence heralded a host of negative outcomes including: metastasis to the lymph nodes and bones and PSA relapse. With further research, he hopes to show that that testing NFKB levels during biopsy will pinpoint patients at risk of aggressive prostate cancer and help personalize therapy.




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.
More

12 innovative Canadian prostate cancer researchers set out to make new Discoveries

Toronto, ON – September 28, 2017: 12 forward-thinking Canadian prostate cancer researchers have been rewarded for their innovation with Movember Discovery Grants.
More

Gray Tools '2017 Together We Are Stronger' campaign a success in creating awareness and raising funds for prostate cancer

BRAMPTON, Ontario, Sept 26, 2017 (GLOBE NEWSWIRE) -- Gray Tools Canada Inc, in cooperation with Prostate Cancer Canada, is proud to announce that its “2017 Together We Are Stronger” initiative raised $4,000, which will go directly towards funding valuable research that is needed to improve the way we diagnose, treat, and support men living with the disease.
More


Click here for news archive